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Abstract
The rapid expansion of flow cytometry applications has outpaced the func-
tionality of traditional manual analysis tools used to interpret flow cytometry
data. Scientists are faced with the daunting prospect of manually identifying
interesting cell populations in 50-dimensional datasets, equalling the com-
plexity previously only reached in mass cytometry. Data can no longer be
analyzed or interpreted fully by manual approaches. While automated gating
has been the focus of intense efforts, there are many significant additional
steps to the analytical pipeline (e.g., cleaning the raw files, event outlier
detection, extracting immunophenotypes). We review the components of a
customized automated analysis pipeline that can be generally applied to large
scale flow cytometry data. We demonstrate these methodologies on data col-
lected by the International Mouse Phenotyping Consortium (IMPC).
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1. Introduction
The current standard approach for analyzing and interpreting flow cy-
tomtery data involves 2D dot plots and Boolean gates in which cell popu-
lations are sequentially selected for further analysis based on gates regions
drawn manually [2]. The large number of possible pairs of parameters (e.g.,
350 markers or 7.18e+23 potential subsets with 50 markers) can make man-
ual gating both extremely labour intensive and time consuming for high
dimensional data [2, 3]. However, this increase in dimensionality has enabled
previously unknown cell populations to be identified [4].
The automated analysis pipeline (Figure 1) we will describe is generaliz-
able to any flow cytometry (FCM) dataset. Our aim is to demonstrate the
comparison between manual and automated analysis and how automated
analysis generally exceeds the performance of manual analysis in terms of
results and time savings.
We use datasets from the Wellcome Trust Sanger Institute (WTSI) and
King’s College London (KCL) generated as part of the International Mouse
Phenotyping Consortium (IMPC) project. Even though we have the full se-
quence of many mammalian genomes, the function of most genes remains
unknown. The IMPC, a $900 million open-access health research project
involving 15 centres across 5 continents is aiming to address this knowledge
gap [5]. This global infrastructure is creating 20,000 knockout mouse strains,
characterizing each strain through a standardized phenotyping protocol, in-
tegrating the data to existing mouse and human disease resources, and finally
providing strains and phenotype data for use by the research community. One
component of this effort is immunophenotyping of spleen and other organs
by FCM, generating approximately 77,000 FCS files. We demonstrate how
automated analysis tools can perform quality checking, automated gating,
and biomarker identification.
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Figure 1: A typical R based automated analysis pipeline. 1. Raw data files are pre-
processed where dead cells and doublets are removed. 2. flowClean or flowAI is used to
clean the data by removing spurious events. 3. Automated gating replicates the manual
gating using flowDensity [6]. flowDensity identifies predefined cell subsets based on the
density distribution of the parent cell population. It estimates the region around each
cell population using characteristics of the marker density distribution. 4. Extraction of
known and unknown cell populations uses flowType [7], where all channels are thresholded
into positive, negative, and neutral populations. 5. In the last step once the significant
immunophenotypes are extracted, RchyOptimyx [8] is used to build an optimized hierarchy
tree showing only significant gating pathways with p-value depicted by colour.
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There are three aims for the FCM analysis in the context of the IMPC,
generalizable to other studies:
1. Detect batch effects and outliers at both sample and dataset level.
2. Enumerate cell populations using both supervised and semi-supervised
computational analysis.
3. Identify cell populations significantly different between sample groups
(e.g., knockout lines and wild type controls.
All the tools that will be discussed in this paper are written in R, a pro-
gramming language for statistical computation and graphics. It provides high
level graphics, interfaces to other languages and debugging facilities. R has
been widely used in the development of tools for computational analysis of
FCM dataset [2], with more than 70% of the tools available for FCM analysis
written in this language. These tools cover a broad spectrum of processing
steps, not limited to data wrangling, quality checking, automated gating
(27 tools approximately covering both supervised and unsupervised cell pop-
ulation identification), biomarker identification and visualization. Most of
these tools are made available by the bioinformaticians at no cost to the re-
search community and include open source code and unrestrictive software
licensing. Many of the tools have been developed to address similar analysis
objectives via different approaches. They might provide optimal results for
different datasets, such that there is no “right” or “best” tool, and using sev-
eral algorithms in combination might yield even better results and exceed the
possibilities offered by manual analysis [2]. In addition, many of these tools
perform one specific task and don’t try to solve the entire analysis pipeline.
This allows tools to be combined and swapped in and out with new advances,
while keeping other parts of the pipeline intact. Since most of these tools are
developed in R, their common infrastructure facilitates this. These tools can
be integrated into FlowJo, FCSExpress, and CytoBank (popular commercial
analysis software packages).
In this paper, we do not intend to present a unified tool which would
incorporate all the tools used in the various stages of the pipeline under one
umbrella. This is because as mentioned earlier, for any one stage, there are
more than one possible tool at each step and using combination of them
might yield better results than manual analysis. In addition, the pipeline is
modular, thus allowing users to swap in newly developed tools. This pipeline
requires users to have some capabilities in R, which can be attained either by
4
  
learning the language, collaborating with people who knows R, or bringing
onto the team a bioinformatician with requisite experience.
Most of the FCM related packages are dependent on flowCore which
provides basic infrastructure and functions to deal with FCM data. It defines
important FCM data classes, a few of which are listed below [9, 10]:
• flowFrame: a class for storing observed quantitative properties for a
population of cells from an FCM experiment
• flowSet: a class for storing FCM raw data from quantitative cell-based
assays
• compensate: class and methods to compensate for spillover between
channels by applying a spillover matrix to a flowSet or a flowFrame
assuming a simple linear combination of values
• transform: a class for transforming flow-cytometry data by applying
scale factors
• filter: a class for representing filtering operations to be applied to flow
data
A goal in automated analysis is to apply the same pipeline on all the FCS
files in a dataset, without file-specific tweaking that often occurs with manual
analysis (Figure 1). Using this approach, the final results are more robust,
and more importantly reproducible. The WTSI & KCL dataset had complete
and in depth analysis available, allowing benchmarking of automated analysis
in order to demonstrate performance. However gating, in the absence of some
external outcome, lacks such a robust and reproducible gold standard and is
benchmarked as the current state-of-the-art.
2. Data
The WTSI & KCL dataset comprised 10-14 dimensional FCS files divided
into 5 panels and 3 organs (spleen, mesenteric lymph node, and bone marrow)
collected over a period of more than three years. Separate pipelines were
developed for the 3 organs and applied to
• > 2000 knockout FCS files
• > 600 wild type FCS files
5
  
• > 500 knockout mouse lines
Table 1: The 5 panels of WTSI & KCL datasets and their respective markers (arranged
in alphabetical order).
T cell B cell Myeloid Bone Marrow P2
CD4 B220 CD11b B220 CD5/Ly6G
CD5 CD5 CD11c BP1 CD11b
CD8a CD21/35 CD45 CD3 CD11c
CD25 CD23 CD86 CD11b CD19
CD44 CD45 CD103 CD24 CD21/35
CD45 CD95 CD317 CD43 CD23
CD62L CD138 F4/80 CD45 CD161
CD161 GL7 Lin (CD3, CD19, CD161) CD138 Ly6C
GITR IgD Ly6C GR1 MHCII
KLRG1 IgG1 Ly6G IgD
TCRδ IgM MHCII IgM
Table 1 shows the markers used for each of the 5 panels. The T cell, B
cell, and Myeloid panels each had two sets of data collected from the spleen
and mesenteric lymph node organs. With these markers, 45 cell populations
were targeted from the T cell panel, 25 from the B cell panel, 22 from the
Myeloid panel, 21 from the Bone marrow panel, and 35 from the P2 panel
(Table A.3 lists the identified cell populations).
3. Methodology
Automated analysis pipelines can generally be divided into pre-processing,
quality checking, cell population identification (using supervised, semi-supervised
or unsupervised automated gating), biomarker identification and visualiza-
tion (Figure 1). Like manual analysis, automated analysis is also performed
on a per tissue and per panel basis.
3.1. Pre-processing
It is important that metadata information linking to the data (FCS files)
be made available. Usually this is provided in the form of spreadsheets,
and contain information such as sex, assay date, birth date, treatment and
outcome, or phenotype such as survival time for each sample. This can then
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be combined to link detailed information on each FCS file. In addition, it
is important that metadata files have a unique ID that matches to the FCS
files. This enables the identification of duplicates within the dataset. The
metadata spreadsheet also is very important for the pipeline because when
the results are sent back to the biologists, the metadata information can be
included with each FCS file and its respective result. This makes it easier
for the biologists to comprehend the results for each file.
The first step of pre-processing ensures that metadata and FCS files are
compatible and eliminates duplicate and corrupted files from further analysis.
Further, files that deviate in the data content (number of channels, set of
markers etc.) and amount of data (lower than defined by user cell number)
are identified and might be removed or reassessed.
In the next step, doublets and dead cells are removed from each file. Then
a global frame is created by storing 1000 random cells from each FCS file of
the dataset. The estimateLogicle() function of the flowCore package is
used on the global frame to automatically estimate the logicle transformation
based on the data. This logicle transformation is then used as a scale factor
for the transformation of each FCS file, which acts as an advantage for display
of FCM data, before they proceed through the next stages in the pipeline
(Figure 2).
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Figure 2: The pre-processing of the FCS files removing dead cells and doublets. The step
starts with raw and unprocessed cells (2A). Dead cells and doublets are next removed
(2B), thus resulting in cells (2C) ready for processing in the next step in the pipeline
(quality checking).
3.2. Quality checking
Once the files pass the pre-processing stage, they go through a quality
checking stage. Two approaches flowClean [11] (Figure 3) and flowAI [12]
(Figure 4) are two freely available R-based tools that identify anomalous
events and clean the data by removing them.
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(A) Detection of anomalies by flowClean (B) After cleaning
Figure 3: Quality check using flowClean to identify anomalous events clean the data. This
is an FCS file downloaded from FlowRepository.org [14].
(A) Detection of anomalies by flowAI (B) After cleaning
Figure 4: Quality check using flowAI to identify anomalous events and clean the data.
This is the same FCS file shown in Figure 3 downloaded from FlowRepository.org.
flowClean is an algorithm that tracks subset frequency changes within
an FCM sample during acquisition, and flags time periods with fluorescence
deviations leading to the emergence of false populations. Anomalous time
periods are reported as a new parameter and added to a revised data file,
allowing users to easily review and exclude those events from further analysis
9
  
[11]. flowAI is the only other currently available algorithm which cleans FCS
files from unwanted events. It is not only an automatic method that adopts
algorithms for the detection of anomalies, but it also has a graphical user
interface implemented in an R/Shiny application, which makes it interactive.
flowAI checks and removes spurious events that derive from abrupt changes
in the flow rate, instability of signal acquisition, and outliers in the lower limit
and margin events in the upper limit of the dynamic range [12]. However
flowAI can on occasion remove more events than necessary when compared
to flowClean (Figures 3 and 4).
3.3. Cell population identification (automated gating)
Automated gating algorithms can generally be broken down into super-
vised and unsupervised approaches. Supervised learning is based on training
a data sample from data source with correct classification already assigned
[15]. In a supervised approach, the data scientist acts as a guide to teach the
algorithm what conclusions it should arrive at. Examples of tools based on
supervised learning method include flowDensity [6], where parameters can be
fixed by the user (though it can also be run in a default mode, but with poorer
results) and DeepCyTOF, a standardization approach for gating, based on
deep learning techniques and means parameterizing [16]. Supervised analy-
sis methods can be customized on a per-population basis and thus have the
advantage of being designed to more closely match manual analysis, which
is often the goal of a researcher. For analytical pipelines where the user’s
goal is to automate the manual gating and mimic it, supervised analysis is
recommended. For best performance this requires being provided with the
gating strategy (that is, the sequence of gates) and using this to optimize the
identification of each cell population of interest, using manual gating analysis
results on a subset of files as a benchmark for performance. This approach
tends to outperform unsupervised approaches. OpenCyto [30] can be used as
an alternative to flowDensity. The larger OpenCyto platform includes flow-
Density. flowDensity is a supervised clustering algorithm which aims to gate
predefined cell populations of interest where the gating strategy is known. It
automates the current practice of manual 2D gating and adjusts the gates for
each FCS data file individually [6], based on parameters set globally for all
files. flowDensity identifies these predefined cell subsets based on characteris-
tics of the marker density distribution (e.g., number, height, width of peaks,
and slope of the distribution curve). A 2D gate consists of two channels
(dimensions) or in other words, a phenotype with two markers. In addition,
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the corresponding expression level for each channel is given. For example, in
Figure 5A phenotypes “CD19+CD20+”, “CD19+CD20-”, “CD19-CD20+”,
and “CD19-CD20-” have markers CD19 and CD20 with expression values
“positive” and “negative” (example adapted from the vignette of flowDensity
package). Parameters can be adjusted on a population-specific basis when
extra information apart from the intrinsic density profile is available (e.g.,
desired percentile cut-off, number of standard deviations from the peak).
(A) (B)
Figure 5: Automated gating using flowDensity, which identifies predefined cell subsets
based on the density distribution of the parent cell population.
deGate() is a built-in function in flowDensity which is used to tweak the
parameters in order to set the correct gating threshold for each population.
deGate() outputs an integer value (vector) of cutoff(s), that is, threshold(s),
on the specified channel. The following code is adapted from the vignette
of flowDensity, which shows deGate() and its parameters. Lines preceded
with the symbol ‘#’ refer to comments in R and have been added for better
understanding.
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## deGate() function of flowDensity and its different
## parameters. User can choose which parameters to use
## and set their associated values.
deGate(flow.frame, channel, n.sd=1.5, use.percentile=FALSE,
percentile=0.95, use.upper=FALSE, upper=NA, talk=TRUE,
alpha=0.1, sd.threshold=FALSE, graphs=FALSE,
all.cuts=FALSE, tinypeak.removal=1/25, adjust.dens=1)
Table A.4 in Appendix A shows the details of the arguments of deGate().
Once the gating thresholds are found, they are used as input parameters
for flowDensity,
flowDensity(obj, channels, position, gates, ...)
For better understanding of how deGate() calculates the gating thresh-
olds and how these thresholds are used as parameters in flowDensity to
gate and find specific populations, we will look into snippets of our codes
(written in R), which is used for gating the T cell panel of the WTSI & KCL
dataset. In addition we also present the 2D gating plots (Figure 6) generated
by flowDensity as part of the result of running the extracted codes. During
the initial writing of the code for getting the thresholds by using the various
parameters of the deGate() function of flowDensity, it is generally based
on a handful of data files selected randomly, which acts as representative of
the entire dataset. Once the script works for these selected files in finding
the correct thresholds, it is applied to the entire dataset to find the gating
thresholds. A FCS file from the WTSI & KCL T cell panel has been added
as Supplemental material (see Appendix A for details), so that the provided
R codes can be tested to generate the bi-variate plots of Figure 6.
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Code Part 01 - For 2D gating plot refer to Figure 6A
## Gating All Events (Ungated population) to get Singlets.
## Plotting FSC-A vs SSC-W
## Using deGate() to determine the gating thresholds.
## In this case two thresholds are found for the
## side scatter channel ‘SSC-W’. Note the use of the
## different parameters of deGate - ‘use.percentile’,
## ‘percentile’ - for tweaking and getting the most
## accurate gating threshold. The ‘percentile’ argument
## gets a value of [0,1) and provides the
## ability to set a threshold based on the
## percentile of the density distribution.
singlets.gate.h <- deGate(f, channel = c("SSC-W"),
use.percentile = T, percentile = 0.90)
singlets.gate.l <- deGate(f, channel = c("SSC-W"),
use.percentile = T, percentile = 0.0001)
## Using the gating thresholds from deGate() as parameters
## into flowDensity to gate Ungated population - ‘f’ -
## to extract Singlets.
singlets.flowD.h <- flowDensity(f, channels = c("FSC-A",
"SSC-W"), position=c(NA, F), gates=c(NA, singlets.gate.h))
singlets.flowD.l <- flowDensity(singlets.flowD.h,
channels = c("FSC-A", "SSC-W"), position = c(NA, T),
gates = c(NA, singlets.gate.l))
## Obtaining the Singlets ‘flowFrame’ from the flowDensity
## output and this will be used as input in the next step
## to extract the Live population.
singlets <- getflowFrame(singlets.flowD.l)
13
  
Code Part 02 - For 2D gating plot refer to Figure 6B
## Gating Singlets population to get Live.
## Plotting Live/Dead vs SSC-A.
## Using deGate() to determine the gating threshold of the
## ‘Live/Dead’ channel. Note the use of the different
## parameters of deGate - ‘use.upper’,‘upper’,
## ‘tinypeak.removal’ - for tweaking and getting the most
## accurate gating threshold. The ‘use.upper’ argument
## is used when the user wants to force the algorithm
## to use the ‘upper’ argument no matter how many peaks are
## found in the density distribution. The ‘upper’ argument
## identifies small cell subsets present at the tail or
## head of the density distribution curve where they are
## typically hidden due to the presence of adjacent
## large cell population. If it is set to ‘‘TRUE" (‘‘FALSE"),
## flowDensity checks the tail (head) of the density
## distribution. The ‘tinepeak.removal’ argument is a number
## in [0,1] to exclude/include tiny peaks in density
## distribution. In this code a high value of 0.90 for the
## ‘tinypeak.removal’ will exclude most of the tiny peaks
## at the tail of the density distribution.
live.gate <- deGate(singlets, channel = c(11),
use.upper = TRUE, upper = T, tinypeak.removal = 0.90)
## Using the gating thresholds from deGate() as parameters
## into flowDensity to gate the Singlets population
## to extract Live.
## Output is the flowDensity object ‘live.flowD’.
live.flowD <- flowDensity(singlets, channels = c(11,4),
position = c(F,NA), gates = c(live.gate,NA))
## Obtaining the Live ‘flowFrame’ from the flowDensity
## output and this will be used as input in the next step
## to extract the Lymphocytes population.
live <- getflowFrame(live.flowD)
14
  
Code Part 03 - For 2D gating plot refer to Figure 6C
## Gating Live population to get Lymphocytes.
## Plotting FSC-A vs SSC-A.
## Using deGate() to determine the gating thresholds of
## ‘FSC-A’ and ’SSC-A’ channels. Note the use of the
## different parameters of deGate - ‘use.upper’,‘upper’,
## ‘use.percentile’, ’percentile’ - for tweaking and
## getting the most accurate gating thresholds.
fsc.a.gate.low <- deGate(live, channel = c(1),
use.upper = TRUE, upper = F, tinypeak.removal = 0.1 )
fsc.a.gate.high <- deGate(live, channel = c(1),
use.percentile = T, percentile = 0.99)
ssc.a.gate <- deGate(live, channel = c(4),
use.percentile = T, percentile = 0.99)
## Using the gating thresholds from deGate() as
## parameters into flowDensity to gate the Live
## population to extract Lymphocytes.
## Output is the flowDensity object ‘lymph.flowD’.
lymph.flowD.temp <- flowDensity(live, channels = c(1,4),
position = c(T, F), gates = c(fsc.a.gate.low, ssc.a.gate))
lymph.flowD <- flowDensity(lymph.flowD.temp, channels=c(1,4),
position = c(F,F), gates = c(fsc.a.gate.high, ssc.a.gate))
## Obtaining the Lymphocytes ‘flowFrame’ from the
## flowDensity output and this will be used as input
## in the next step of gating.
lymph <- getflowFrame(lymph.flowD)
15
  
(A) Singlets (B) Live
(C) Lymphocytes
Figure 6: 2D plots generated after running Code Parts 01-03. deGate() of flowDensity is
used to generate the gating thresholds which are used for gating the ungated population to
extract the singlets population in 6A. Singlets are then further gated by using the gating
threshold of the Live/Dead channel to obtain the Live population in 6B. In 6C, the Live
population is gated by using the thresholds of the channels FSC-A and SSC-A, generated
by deGate() to extract the lymphocyte population.
Figure 7 illustrates flowDensity automated gating of populations, with
two markers in bi-variate plots, similar to what is seen in manual gating.
Gating thresholds are not static, they move objectively to gate the correct
cell subsets for each file (Figure 7A). flowDensity also identifies very rare
16
  
cell subsets (Figure 7B).
(A)
(B)
Figure 7: flowDensity automated gating of populations in bi-variate plots, similar to what
is seen in manual gating. The gates of flowDensity move objectively as the population
moves. The gating thresholds of the CD43 and CD45 markers changes as the distribution
and density of the lymphocyte population changes from one sample to another, thus
gating the correct CD45 population (6A). In addition, flowDensity can identify very rare
cell populations (Plasma cells in 6B).
flowDensity can accept control data (e.g., FMO controls) for each channel
used in gating. When a control sample is included, the gating threshold is
calculated based on the control population. The user first sets the desired
gating thresholds on the control data, and these gating thresholds are later
applied to the data files corresponding to that control data file. Appendix A
Figures A.15 and A.16 illustrates how complete automated gating plots by
flowDensity look like once they are complete along with the proportions and
event counts for each populations saved in spreadsheets.
17
  
Unsupervised learning algorithms identify patterns in input data with-
out user training. The lack of direction in unsupervised learning algorithm
can sometimes be advantageous, since it enables the algorithm to look for
patterns that have not been previously considered [15]. Examples of unsuper-
vised learning algorithms have been based on k-means clustering, principal
and independent component analysis, and association rules. In the analysis
of big FCM data, unsupervised approaches use clustering methods to detect
cell populations. Clustering analysis may be performed on data from a single
biological sample, on data from multiple samples on a per-sample basis, or on
combined data from multiple samples. Detected clusters or cell populations
can then be analyzed individually or compared across samples. Unsupervised
procedures allow previously unknown cell populations to be described in an
unbiased, data-driven manner. This type of exploratory analysis is difficult
with manual gating, especially when analyzing high-dimensional data [17].
Many unsupervised algorithms have been developed and evaluated through
FlowCAP community-based challenges[18, 19]: FLOCK [20], flowClust [21],
flowMeans [22], flowMerge [23], flowPeaks [24], immunoClust [25], Pheno-
Graph [26], SamSPECTRAL [27], and SWIFT [28]. A recent review by We-
ber and Robinson [17] identified FlowSOM [29], as the current best approach
for unsupervised analysis.
Once the results of the cell population identification analysis is ready,
calculating the variations between manual and automated gating is the next
step in moving the pipeline into production use. This is done by calculating
the coefficient of variation (CV) [31] for each population within a dataset
for both manual and automated analysis and then these CVs are compared
population by population.
3.4. Biomarker discovery
After gating, the next step in the pipeline is biomarker discovery step,
with the goal to identify cell populations that are significantly associated
with an outcome of interest, in the case of our example dataset cell popula-
tions that are at different proportions in KO mice versus WT. The approach
is generalizable to any case where samples can be divided into two groups
based on some outcome of interest such as different disease types [32], time to
onset of symptoms [33], or different sample types [34]. The approach can be
based on any approach to identify cell populations but we recommend basing
this on flowDensity (discussed in Section 3.3) as the final results will be easily
18
  
interpretable by the biologist. Channels were thresholded into positive, neg-
ative, and neutral populations using the tool flowType [7]. Therefore, for any
number of markers (M) used as input parameters in flowType, the number of
possible cell populations generated is 3 to the power of M. As an example, if
there are 10 markers, the gating thresholds of these 10 markers would gen-
erate 310, that is, approximately 60,000 populations, based on the manually
specified thresholds. 60,000 cell populations is a large number, therefore the
chance of getting false positive hits is high; hence, the next task is to filter
this large set of populations to identify significant immunophenotypes. The
Wilcoxon rank sum test [35] is used followed by p-value adjustment [36].
For the p-value adjustment, the Benjamini–Hochberg procedure is used [37].
Cell populations with p-value of 0.05 and less are considered as significant
and those greater are screened out. A large percentage of cell population is
excluded because they have very few events. Populations are excluded when
both wild type and knockout population sizes have less than 200 cell counts
(this threshold of 200 cells is further discussed in details later). This helps
to reduce the 60,000 cell populations set into a much smaller one (Figure 8).
An alternate to Wilcoxon rank sum test is a multiple group comparison
test such as one-way analysis of variance (ANOVA) or Kruskal–Wallis test,
which could be applied for centres where there are more than one set of WTs
(the groupings of the WTs are based on how and where the experiments have
been carried out). Once a statistically significant p-value (usually meaning
p < 0.05) is returned, a post hoc test can be applied to determine between
exactly which two datasets the difference lies. A few such post hoc tests
include, Tukey’s Honestly Significant Difference Test (Tukey–Kramer test),
Newman–Keuls test, Boneferroni’s test, Dunnett’s test, Scheffe’s test, Dunn’s
test and so on [38].
In order to address the question if there is an agreement between the
assessment techniques of WTs and KOs, intraclass correlation coefficient
(quantitative method) or Bland-Altman plot (graphical method in which
the difference between two variables x and y is plotted against the mean
of x and y) can be applied [38]. Since FCM datasets involve time versus
fluorescence analysis, statistical analysis involving a difference between time-
to-event trends between the WTs and KOs can also be applied. A few such
applicable tests are Cox-Mantel test, Gehans (generalized Wilcoxon) test, or
log-rank test [38].
19
  
Figure 8: High dimensional biomarker discovery using flowType
As part of further screening to identify significant immunophenotypes,
Figure 9 shows a bi-variate plot where the x-axis is the average cell propor-
tion over all mice of a particular knockout line and the y-axis is the log10 of
the adjusted p-value. The black horizontal line signifies the adjusted p-value
of 0.05 (value of -log10(0.05) = 1.30) and any dots below this line colored as
blue in this plot symbolize significant cell populations, that is, populations
with adjusted p-value < 0.05. The blue dots with orange outlines are the
15 populations with the largest effect size (that is, significant cell popula-
tions with the highest proportions). The blue dots with green outlines are
the 15 most significant populations, that is, cell populations with the lowest
adjusted p-values. In some knockouts, populations which fall in both cate-
gories were also found. Such cell populations were marked and highlighted
separately.
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Figure 9: A plot of log10(adjusted p-values) for a particular knockout vs the average
proportion over all mice. The black horizontal line signifies the adjusted p-value of 0.05
(value of -log10(0.05) = 1.30) and any dots below this line colored as blue symbolizes
significant cell populations, that is, populations with adjusted p-value < 0.05. The orange
rings highlight the 15 populations with the largest effect size (that is, significant cell
populations with the highest proportions). The green rings highlight the populations that
have the lowest adjusted p-values.
Extremely rare cell populations are often identified as being statistically
significant (Figure 9). These are often identified by the co-expression of 12
or more markers in combinations not commonly seen, making hypothesis to
their biological function a challenge. For this study, cell populations with
less than 200 events were discarded as the number of significant phenotypes
identified increased sharply when including populations with very few events,
likely indicating a raise in false positive hits (Figure 10). Setting a threshold
based on how many events are enough or if they are real is a perplexing
problem in FCM analysis due to its uniqueness among all other biological
technologies by providing an enormous number of measurements on which
to base conclusions [39]. Thresholding out smaller cell populations focuses
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attention on populations with 6-8 markers in the label which are more eas-
ily understood. However, the threshold of 200 cells we used for this study
may cause the loss of some biologically meaningful cell populations, and was
used in our first pass analysis to identify the hits of most interest to our
collaborators, and taken in consultation with them. Given sufficient time
and resources all significant hits of potential interest for any study should be
further investigated.
Figure 10: Setting the threshold to a minimum of 200 cell counts for each population.
Once the significant immunophenotypes are extracted, RchyOptimyx [8]
is used to build an optimized hierarchy tree with colour associated to the
magnitude of importance of the parameter (Figure 11 where adjusted p-
values are visualised by colour).
Cell populations are arranged in a hierarchy starting from all cells, with
more significant populations (i.e. populations with lower adjusted p-values)
colored yellow and orange while the less significant ones are colored blue
(Figure 11).
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4. Results
When the automated results were compared with that of the manual
analysis, high correlation was observed between the two approaches (Figures
12 and 13) (Note that this statement will be revised at the proof stage by
adding citation). The CV of the populations (WTSI & KCL bone marrow
dataset) in Figure 13 are expressed as fractions of CD45+ cells and it can be
seen that the CV for automated analysis is lower than that of manual gating
for all the populations. In addition, automated gating reduced variations
seen over time for manual gating (Figure 13, Appendix A Figure A.17). A
manuscript on the comparison between the automated and manual analysis
results of the WTSI & KCL datasets are in preparation by the KCL team
in London, UK, where greater details are provided on how the automated
analysis superseded the manual analysis.
Figure 12: High correlation between automated and manual results (aggregated spleen
and bone marrow datasets of WTSI & KCL).
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Figure 13: Comparison of coefficient of variations of automated versus manual results
(WTSI & KCL bone marrow dataset).
4.1. Additional outcomes
Phenodeviant mice were observed at a frequency of approximately 20% of
the total knockout lines analyzed for the WTSI & KCL subset of the IMPC
data. One example was a hit in an activated NK cell subset, which was not
identified during the manual analysis (see Figure 14).
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Figure 14: Hit in an activated NK cell subset, identified by unsupervised analysis step and
which has not been detected by manual analysis.
4.2. Time requirements & Efficiency
Automated gating can offer considerable time savings. The time spent
on the initial setup of the pipeline is more or less the same for manual and
automated analysis. Once this setup is completed, the time spent in tweaking
the manual analysis can be 5-15 minutes/FCS file. This information is based
on the time taken by the KCL team in London, UK who did the manual
analysis on the WTSI & KCL dataset. On the other hand, for automated
analysis, run time is 5 seconds per file with no manual intervention required,
resulting in the same gates. This represents a time saving of 533 working
days for the WTSI & KCL dataset.
5. Conclusion
The methodologies we have presented in this paper are generalizable to
any FCM dataset. The same pre-processing pipeline is used for most centres
without individual customization and our computational tools can find cell
populations relatively similar to those identified by manual gating. High cor-
relations were seen between manual and automated analysis with automated
gating on the whole reducing variations seen over time. In addition, novel
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biomarkers can be identified using automated analysis that would be missed
by even thorough manual analysis due to the limitations in exploring high
dimensional datasets. Automated gating also resulted in considerable time
savings.
6. Software Availability
All the tools discussed in this paper are written in R and are freely avail-
able in Bioconductor [40] or from the developers own private repository.
Table 2: The various R-based tools that have been discussed in this paper and used in our
automated pipeline.
Name Availability Function
flowClean Free (Bioconductor) Removes anomalous events & cleans FCS files
flowAI Free (Bioconductor) Removes anomalous events & cleans FCS files
flowDensity Free (Bioconductor) Automated density-based cell population identification
flowType Free (Bioconductor) Phenotyping FCM assays
RchyOptimyx Free (Bioconductor) Cellular hierarchy optimization for FCM
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Table A.4: Arguments of the built-in function deGate - adapted from the vignette of
flowDensity
Arguments
flow.frame a ‘FlowFrame’ object.
channel a channel’s name or its corresponding index in the ‘flow.frame’.
n.sd an integer coefficient for the standard deviation to determine the
threshold based on the standard deviation if ‘sd.threshold’ is TRUE.
use.percentile if TRUE, forces to return the ‘percentile’th threshold.
percentile a value in [0,1] that is used as the percentile. The default value is 0.95.
upper if TRUE, finds the change in the slope at the tail of the density curve,
if FALSE, finds it at the head. Default value is set to ‘NA’.
use.upper Logical. If TRUE, forces to return the inflection point based on the
first (last) peak if upper=F (upper=T). Default value is set to ‘FALSE’.
talk Logical. If TRUE, Prints a message if only one peak is found,
or when inflection point is used to set the gates.
alpha a value in [0,1) specifying the significance of change in the slope being
detected. This is by default 0.1, and typically need not be changed.
sd.threshold if TRUE, uses ‘n.sd’ times standard deviation as the threshold.
Default value is set to ‘FALSE’.
graphs if TRUE, generates density distribution plot plus its corresponding
threshold.
all.cuts if TRUE, returns all the identified cutoff points, i.e. potential
thresholds for that channel. Default value is set to ‘FALSE’.
tinypeak.removal A number in [0,1] to exclude/include tiny peaks in density distribution.
adjust.dens The smoothness of density in [0,Inf] to be used in density(.).
The default value is 1 and should not be changed unless necessary.
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Figure A.15: Complete automated gating of a sample WTSI & KCL T cell spleen organ
data.
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Figure A.16: Complete automated gating of a sample WTSI & KCL bone marrow data.
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(A) (B)
Figure A.17: Automated gating compared to manual gating reduced variations seen over
time. Hardy Fractions population from the WTSI & KCL bone marrow dataset.
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Highlights 
• Customized automated analysis pipeline that can be applied to large scale 
flow cytometry data is proposed. 
• Detect batch effects and outliers at both sample and dataset level 
• Enumerate cell populations using both supervised and semi-supervised 
computational analysis. 
• Identify cell populations significantly different between knockout lines and 
wild type controls. 
 
